NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7%
Thu, 14 Feb

NATCO PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m5,6225,4355,5672.4%-1.0%
Other incomeRs m114400233-41.8%104.4%
TurnoverRs m5,7365,8355,800-0.6%1.1%
ExpensesRs m2,7573,2303,4837.8%26.3%
Gross profitRs m2,8652,2052,084-5.5%-27.3%
DepreciationRs m1722022072.5%20.3%
InterestRs m43506326.0%46.5%
Profit before taxRs m2,7642,3532,047-13.0%-25.9%
TaxRs m590537454-15.5%-23.1%
Profit after taxRs m2,1741,8161,593-12.3%-26.7%
Gross profit margin%51.040.637.4
Effective tax rate%21.322.822.2
Net profit margin%37.931.127.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 1.0% on a year-on-year (YoY) basis. The expenses were up by 26.3% YoY during the same period.
  • The company's operating profit declined by 27.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 37.4% in 3QFY19 as against 51.0% in 3QFY18.
  • Depreciation charges increased by 20.3% and finance costs increased by 46.5% YoY, respectively.
  • Other income increased by 104.4% YoY during the quarter.
  • Net profit for the quarter declined by 26.7% YoY. Net profit margins during the quarter declined from 37.9% in 3QFY18 to 27.5% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 2.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 7.8% QoQ during the same period.
  • The company's operating profit declined by 5.5% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 37.4% in 3QFY19 as against 40.6% in 2QFY18.
  • Net profit for the quarter declined by 12.3% QoQ, while net profit margins declined from 31.1% in 2QFY18 to 27.5% in 3QFY19.

To see how NATCO PHARMA has performed over the last eight quarters, please visit here.

NATCO PHARMA Share Price Performance

Over the last one year, NATCO PHARMA share price has moved up from Rs 782.8 to Rs 608.0, registering a Loss of Rs 174.8 or around 22.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,757.6 (up 0.6%). Over the last one year it has moved down from 14,417.3 to 13,757.6, a gain of 660 points (down 4.6%).

Overall, the S&P BSE SENSEX is up 5.4% over the year.

Current Valuations

At the current price of Rs 608.0, the price to earnings (P/E) ratio of NATCO PHARMA stands at 12.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.3 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Dec 13, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ORCHID PHARMA LTD COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS